New Diagnostics Using Recombinant DNA Technology

| Home | | Pharmaceutical Microbiology | | Pharmaceutical Microbiology |

Chapter: Pharmaceutical Microbiology : Recombinant DNA Technology

For many years clinical diagnostic laboratories had limitations in the detection of pathogenic bacteria and parasites due to time constraints in the identification of these agents, as they required to be cultured, a time-consuming procedure detrimental to the patients’ health.


NEW  DIAGNOSTICS  USING  RECOMBINANT DNA  TECHNOLOGY

 

For many years clinical diagnostic laboratories had limitations in the detection of pathogenic bacteria and parasites due to time constraints in the identification of these agents, as they required to be cultured, a time-consuming procedure detrimental to the patients’ health. In addition, many inherited genetic disorders could not be identified owing to the lack of appropriate techniques and the unavailability of the human genome sequence. The rapid developments in molecular biology have enabled modern medicine to overcome some of these problems. Currently, a good diagnostic test must be specific for a target molecule, sensitive enough to detect minute levels of that molecule, rapid and technically simple.

 

Contact Us, Privacy Policy, Terms and Compliant, DMCA Policy and Compliant

TH 2019 - 2022 pharmacy180.com; Developed by Therithal info.